DABRAFENIB vs DALTEPARIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs DALTEPARIN: Safety Overview
| Metric | DABRAFENIB | DALTEPARIN |
|---|---|---|
| Total FAERS Reports | 19,305 | 3,570 |
| Deaths Reported | 4,165 | 789 |
| Death Rate | 21.6% | 22.1% |
| Hospitalizations | 5,325 | 1,443 |
| Average Patient Age | 58.3 yrs | 67.7 yrs |
| % Female Patients | 48.0% | 39.7% |
| FDA Approval Date | Mar 16, 2023 | Apr 4, 2002 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |